Search Results - "SAWYER, Michael B"

Refine Results
  1. 1

    Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index by MARTIN, Lisa, BIRDSELL, Laura, MACDONALD, Neil, REIMAN, Tony, CLANDININ, M. Thomas, MCCARGAR, Linda J, MURPHY, Rachel, GHOSH, Sunita, SAWYER, Michael B, BARACOS, Vickie E

    Published in Journal of clinical oncology (20-04-2013)
    “…Emerging evidence suggests muscle depletion predicts survival of patients with cancer. At a cancer center in Alberta, Canada, consecutive patients with cancer…”
    Get full text
    Journal Article
  2. 2

    Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study by Prado, Carla MM, BSc, Lieffers, Jessica R, RD, McCargar, Linda J, Prof, Reiman, Tony, MD, Sawyer, Michael B, MD, Martin, Lisa, MSc, Baracos, Vickie E, Prof

    Published in The lancet oncology (01-07-2008)
    “…Summary Background Emerging evidence on body composition suggests that sarcopenic obesity (obesity with depleted muscle mass) might be predictive of morbidity…”
    Get full text
    Journal Article
  3. 3

    Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment by PRADO, Carla M. M, BARACOS, Vickie E, MCCARGAR, Linda J, REIMAN, Tony, MOURTZAKIS, Marina, TONKIN, Katia, MACKEY, John R, KOSKI, Sheryl, PITUSKIN, Edith, SAWYER, Michael B

    Published in Clinical cancer research (15-04-2009)
    “…Purpose: Body composition has emerged as an important prognostic factor in cancer patients. Severe depletion of skeletal muscle (sarcopenia) and, hence, of…”
    Get full text
    Journal Article
  4. 4

    Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study by ANTOUN, Sami, BIRDSELL, Laura, SAWYER, Michael B, VENNER, Peter, ESCUDIER, Bernard, BARACOS, Vickie E

    Published in Journal of clinical oncology (20-02-2010)
    “…PURPOSE Effects of specific antineoplastic therapies on progression of cancer-associated wasting remain uncharacterized. We selected a targeted therapy,…”
    Get full text
    Journal Article
  5. 5

    The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats by Lin, Xiaoxi B, Farhangfar, Arazm, Valcheva, Rosica, Sawyer, Michael B, Dieleman, Levinus, Schieber, Andreas, Gänzle, Michael G, Baracos, Vickie

    Published in PloS one (14-01-2014)
    “…CPT-11 is a drug used as chemotherapy for colorectal cancer. CPT-11 causes toxic side-effects in patients. CPT-11 toxicity has been attributed to the activity…”
    Get full text
    Journal Article
  6. 6

    1H-NMR urinary metabolomic profiling for diagnosis of gastric cancer by Chan, Angela W, Mercier, Pascal, Schiller, Daniel, Bailey, Robert, Robbins, Sarah, Eurich, Dean T, Sawyer, Michael B, Broadhurst, David

    Published in British journal of cancer (12-01-2016)
    “…Background: Metabolomics has shown promise in gastric cancer (GC) detection. This research sought to identify whether GC has a unique urinary metabolomic…”
    Get full text
    Journal Article
  7. 7

    Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma by Meza-Junco, Judith, Montano-Loza, Aldo J, Baracos, Vickie E, Prado, Carla M.M, Bain, Vincent G, Beaumont, Crystal, Esfandiari, Nina, Lieffers, Jessica R, Sawyer, Michael B

    Published in Journal of clinical gastroenterology (01-11-2013)
    “…BACKGROUND AND AIMS:Abnormal body composition such as severe skeletal muscle depletion or sarcopenia has emerged as an independent predictor of clinical…”
    Get full text
    Journal Article
  8. 8

    Urine Metabolite Analysis Offers Potential Early Diagnosis of Ovarian and Breast Cancers by SLUPSKY, Carolyn M, STEED, Helen, WELLS, Tiffany H, DABBS, Kelly, SCHEPANSKY, Alexandra, CAPSTICK, Valerie, FAUGHT, Wylam, SAWYER, Michael B

    Published in Clinical cancer research (01-12-2010)
    “…Metabolomics is a new, rapidly expanding field dedicated to the global study of metabolites in biological systems. In this article metabolomics is applied to…”
    Get full text
    Journal Article
  9. 9

    A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review by Oliveira, Camila L.P., MSc, Mattingly, Stephanie, PhD, Schirrmacher, Ralf, MD, Sawyer, Michael B., MD, Fine, Eugene J., MD, Prado, Carla M., PhD, RD

    “…Abstract The predominant use of glucose anaerobically by cancer cells (Warburg effect) may be the most important characteristic the majority of these cells…”
    Get full text
    Journal Article
  10. 10

    Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma by Chu, Michael P., Li, Yuetong, Ghosh, Sunita, Sass, Shelley, Smylie, Michael, Walker, John, Sawyer, Michael B.

    Published in Journal of cachexia, sarcopenia and muscle (01-06-2020)
    “…Background Body composition is minimally investigated in an immunotherapy era. Specific body composition signals such as myosteatosis may reflect aspects of…”
    Get full text
    Journal Article
  11. 11

    Prediction of whole body composition utilizing cross-sectional abdominal imaging in pediatrics by Deyell, Rebecca J., Desai, Sunil, Gallivan, Andrea, Lim, Alecia, Sawyer, Michael B., Heymsfield, Steven B., Shen, Wei, Baracos, Vickie E.

    Published in European journal of clinical nutrition (01-06-2023)
    “…Background Although body composition is an important determinant of pediatric health outcomes, we lack tools to routinely assess it in clinical practice. We…”
    Get full text
    Journal Article
  12. 12

    Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats by Lin, Xiaoxi B, Dieleman, Levinus A, Ketabi, Ali, Bibova, Ilona, Sawyer, Michael B, Xue, Hongyu, Field, Catherine J, Baracos, Vickie E, Gänzle, Michael G

    Published in PloS one (26-07-2012)
    “…Intestinal microbiota mediate toxicity of irinotecan (CPT-11) cancer therapies and cause systemic infection after CPT-11-induced loss of barrier function. The…”
    Get full text
    Journal Article
  13. 13

    Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus by Hopkins, Jessica J., Skubleny, Daniel, Bigam, David L., Baracos, Vickie E., Eurich, Dean T., Sawyer, Michael B.

    Published in Annals of surgical oncology (01-05-2018)
    “…Background Measurement of body composition by computed tomography (CT) is an advancing field. Sarcopenia, myosteatosis, and visceral obesity (VO) have been…”
    Get full text
    Journal Article
  14. 14

    Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity by PRADO, Carla M. M, BARACOS, Vickie E, MCCARGAR, Linda J, MOURTZAKIS, Marina, MULDER, Karen E, REIMAN, Tony, BUTTS, Charles A, SCARFE, Andrew G, SAWYER, Michael B

    Published in Clinical cancer research (01-06-2007)
    “…Purpose: Evidence suggests that lean body mass (LBM) may be useful to normalize doses of chemotherapy. Data from a prospective study were used to determine if…”
    Get full text
    Journal Article
  15. 15

    Potential role of metabolomics in diagnosis and surveillance of gastric cancer by Chan, Angela W, Gill, Richdeep S, Schiller, Daniel, Sawyer, Michael B

    Published in World journal of gastroenterology : WJG (28-09-2014)
    “…Gastric cancer is one of the deadliest cancers worldwide, and is especially prevalent in Asian countries. With such high morbidity and mortality, early…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer by Wong, Grace G., Ha, Vincent, Chu, Michael P., Dersch-Mills, Deonne, Ghosh, Sunita, Chambers, Carole R., Sawyer, Michael B.

    Published in Clinical colorectal cancer (01-03-2019)
    “…Proton pump inhibitors (PPIs) have been implicated in the impaired absorption of various oral oncologic therapies. Significantly reduced 3-year recurrence-free…”
    Get full text
    Journal Article
  18. 18

    Assessment of nutritional status in cancer--the relationship between body composition and pharmacokinetics by Prado, Carla M M, Maia, Yara L M, Ormsbee, Michael, Sawyer, Michael B, Baracos, Vickie E

    Published in Anti-cancer agents in medicinal chemistry (01-10-2013)
    “…Several nutritional assessment tools have been used in oncology settings to monitor nutritional status and its associated prognostic significance. Body…”
    Get more information
    Journal Article
  19. 19

    Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy by Chu, Michael P, Lieffers, Jessica, Ghosh, Sunita, Belch, Andrew R, Chua, Neil S, Fontaine, Amelie, Sangha, Randeep, Turner, A Robert, Baracos, Vickie E, Sawyer, Michael B

    Published in PloS one (01-06-2015)
    “…Skeletal muscle radio-density (SMD) measures muscle radiation attenuation (in Hounsfield Units, HU) on computed tomography (CT) scans. Low SMD is prognostic of…”
    Get full text
    Journal Article
  20. 20

    Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity by Prado, Carla MM, Antoun, Sami, Sawyer, Michael B, Baracos, Vickie E

    “…PURPOSE OF REVIEWA common feature of cancer patients is loss of lean tissue, specifically skeletal muscle, which may be the result of the tumor or a…”
    Get full text
    Journal Article